SLC25A1 and breast cancer: Interestingly, Slc25a1-/- embryos also displayed an enrichment of tumor-associated transcriptional signatures involved in breast cancer, neuroblastoma, ovarian cancer, and others, as well as induction of the p53 tumor suppressor (Supplementary Fig. 4B).